Does Multiple Myeloma Cause Macrocytosis?
No, multiple myeloma does not typically cause macrocytosis—the anemia in myeloma is characteristically normochromic and normocytic. 1
Characteristic Anemia Pattern in Multiple Myeloma
The anemia associated with multiple myeloma has well-defined characteristics that are consistently described across major guidelines:
- Normochromic and normocytic anemia is the typical presentation 1
- Present in approximately 75% of patients at diagnosis 1
- Mean corpuscular volume (MCV) falls within the normal range of 80-100 fL 2
The European Myeloma Network guidelines explicitly state that anemia in MM is "usually normochromic and normocytic" 1. This is echoed by ESMO guidelines, which describe the anemia as "normochromic, normocytic" 3.
Mechanisms of Anemia in Myeloma
The normocytic anemia in MM results from several factors 1:
- Bone marrow infiltration by myeloma cells reducing erythroid precursors
- Erythropoietin deficiency (especially with renal impairment)
- Decreased responsiveness of erythroblasts to erythropoietin
- Impaired iron utilization due to increased hepcidin production
- Most importantly: induction of apoptosis of erythroblasts by myeloma cells
When Macrocytosis Occurs with Monoclonal Gammopathy
While macrocytosis is not a typical feature of multiple myeloma itself, there is limited evidence suggesting an association between monoclonal gammopathy and macrocytosis in some cases:
- A retrospective study found that 5% of patients with monoclonal gammopathy had unexplained macrocytosis after thorough evaluation 4
- These patients showed megaloblastoid maturation of erythroid precursors on bone marrow examination 4
- However, this represents a rare association rather than a typical manifestation
Clinical Implications
If a patient with multiple myeloma presents with macrocytosis, look for alternative explanations:
- Vitamin B12 or folate deficiency (most common cause of macrocytosis) 2, 5
- Alcohol use 5
- Liver disease 5
- Hypothyroidism 5
- Medications (hydroxyurea, chemotherapy agents) 2
- Myelodysplastic syndrome 2, 5
The presence of macrocytosis in a myeloma patient should prompt investigation for these concurrent conditions rather than being attributed to the myeloma itself. This is particularly important because macrocytosis with MCV >100 fL typically indicates a separate pathologic process requiring specific evaluation and treatment 2.